This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
protein
product name :
Human Apo-Transferrin Protein, CF
catalog :
3188-AT-100MG
quantity :
100 mg (also 1 g)
price :
133 USD
citations: 10
Reference
Gantner C, Weatherbee B, Wang Y, Zernicka Goetz M. Assembly of a stem cell-derived human postimplantation embryo model. Nat Protoc. 2025;20:67-91 pubmed publisher
Halld xf3 rsson S, Hillringhaus L, Hojer C, Murányi A, Schraeml M, Lange M, et al. Development of a first-in-class antibody and a specific assay for α-1,6-fucosylated prostate-specific antigen. Sci Rep. 2024;14:16512 pubmed publisher
Chongsaritsinsuk J, Rangel Angarita V, Mahoney K, Lucas T, Enny O, Katemauswa M, et al. Quantification and site-specific analysis of co-occupied N- and O-glycopeptides. bioRxiv. 2024;: pubmed publisher
Bratti M, Stubbs E, Kolodych S, Souchet H, Kelly L, Merlin J, et al. INA03: A Potent Transferrin-Competitive Antibody-Drug Conjugate against CD71 for Safer Acute Leukemia Treatment. Mol Cancer Ther. 2024;23:1159-1175 pubmed publisher
Lau K, Amadei G, Zernicka Goetz M. Assembly of complete mouse embryo models from embryonic and induced stem cell types in vitro. Nat Protoc. 2023;18:3662-3689 pubmed publisher
Agliardi C, Guerini F, Zanzottera M, Bolognesi E, Meloni M, Riboldazzi G, et al. The VDR FokI (rs2228570) polymorphism is involved in Parkinson's disease. J Neurol Sci. 2021;428:117606 pubmed publisher
Lim K, Bittel A, Maruyama R, Echigoya Y, Nguyen Q, Huang Y, et al. DUX4 Transcript Knockdown with Antisense 2'-O-Methoxyethyl Gapmers for the Treatment of Facioscapulohumeral Muscular Dystrophy. Mol Ther. 2021;29:848-858 pubmed publisher
Giadone R, Liberti D, Matte T, Rosarda J, Torres Arancivia C, Ghosh S, et al. Expression of Amyloidogenic Transthyretin Drives Hepatic Proteostasis Remodeling in an Induced Pluripotent Stem Cell Model of Systemic Amyloid Disease. Stem Cell Reports. 2020;15:515-528 pubmed publisher
Zeno W, Thatte A, Wang L, Snead W, Lafer E, Stachowiak J. Molecular Mechanisms of Membrane Curvature Sensing by a Disordered Protein. J Am Chem Soc. 2019;141:10361-10371 pubmed publisher
Staquicini F, Ozawa M, Moya C, Driessen W, Barbu E, Nishimori H, et al. Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma. J Clin Invest. 2011;121:161-73 pubmed publisher
product information
master code :
3188-AT
SKU :
3188-AT-100MG
product name :
Human Apo-Transferrin Protein, CF
unit size :
100 mg (also 1 g)
description :
The Human Apo-Transferrin Protein, CF from R&D Systems is derived from Human Plasma. The Human Apo-Transferrin Protein, CF has been validated for the following applications: Bioactivity.
target :
Apo-Transferrin
category :
Proteins and Enzymes
buffer :
Lyophilized from a 0.2 ╡m filtered solution in deionized water.
conjugate :
Unconjugated
species :
Human
observed molecular weight :
76-81 kDa, reducing conditions
details of functionality :
Measured in a serum-free cell proliferation assay using CHO-K1 cells. The ED50 for this effect is 6.00 ╡g/mL.
endotoxin note :
<0.10 EU per 1 ╡g of the protein by the LAL method.
applications :
Bioactivity
source long :
Human plasma-derived Apo-Transferrin protein The human plasma used for the isolation of this product were certified by the supplier to be negative for HIV I and II antibodies, Hepatitis C antibody and Hepatitis B antigen at the time of shipment. Human blood products should always be treated in accordance with universal handling precautions.
source short :
Human Plasma
USD :
133 USD
alt names :
ApoTransferrin, CD71, p90, T9, TFR, TFR1, TFRC, TR, transferrin receptor (p90, CD71), TRFR
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt at -20 to -70 ░C as supplied. 1 month at 2-8 ░C under sterile conditions after reconstitution. 3 months at -20 to -70 ░C under sterile conditions after reconstitution.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.